Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Sarcoma|Melanoma|Lung Cancer|Breast Cancer|High Grade Gliomas
Interventions: DRUG: F-18 RGD-K5
Sponsor: Siemens Molecular Imaging